Restart Life Sciences Corp.
OTC: NMLSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Steve Loutskou
- Headquarters
- Vancouver, Canada
- IPO year
- 2011
- Market cap
- $1.8M
- Website
- https://www.restartlife.co
Loading NMLSF…
Loading profile data…Frequently asked questions about NMLSF
What does Restart Life Sciences Corp. (NMLSF) do?
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome...
Where does NMLSF trade?
Restart Life Sciences Corp. (NMLSF) trades on the Other OTC.
What sector is NMLSF in?
Restart Life Sciences Corp. (NMLSF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Restart Life Sciences Corp.?
Steve Loutskou is the chief executive officer of Restart Life Sciences Corp. (NMLSF).
Where is Restart Life Sciences Corp. headquartered?
Restart Life Sciences Corp. is headquartered in Canada.
Does NMLSF pay a dividend?
Restart Life Sciences Corp. (NMLSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NMLSF go public?
Restart Life Sciences Corp. (NMLSF) completed its initial public offering in 2011.